WinstonWınston
Back
Phreesia logo

Phreesia

PHR
56
Medical - Healthcare Information Services · Healthcare
Price
$12.12
+0.12 (+1.00%)
Market Cap
$749.2M
Winston Score
56
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Aug 23, 2026 · filings through Apr 30, 2026
How the score breaks down
Quality
Mixed
Growth
Good
Cash Flow
Exceptional
Stability
Good
Valuation
Good

Share count rising — dilution

+23.3% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 49.9M (2022) → 61.5M (2026)

Winston Score History

The full picture

Phreesia makes software that helps doctors' offices and hospitals manage patient check-ins. Instead of filling out paper forms in a waiting room, patients use Phreesia's digital tablets or mobile tools to enter their information, sign forms, and even pay their bills. The company sells its platform to healthcare providers across the United States, serving medical practices of all sizes.

Phreesia charges healthcare providers a recurring software fee, which gives it a subscription-style revenue base. It also earns money from payment processing when patients pay their medical bills through the platform, and from life sciences companies that use Phreesia's network to deliver health information to patients. The company operates almost entirely in the U.S. and has built a large installed base of provider clients, which makes switching to a competitor costly and time-consuming. Its main challenge is reaching consistent profitability, as it continues to spend heavily on sales and technology while operating margins remain near breakeven.

Politician Trades

2 trades / 12mo

1 Congressional buy and 1 sell on PHR in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+12.9% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

+173.2% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$121M/ year

Flat (+4% vs prior year)

25.3% of revenue

In line with sector average (18%)

Steady R&D investment year-over-year

Insider Activity

20.2%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$141M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth + cash flow

Phreesia is a rare growth stock that's already generating positive cash flow while growing at 13%. The Winston Score doesn't fully credit this transition from "burner" to "earner."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
59.2%
Premium pricing power — 59.2% gross margin
Profit after running costs
Operating Margin
5.3%
Thin — 5.3% operating margin
Return on the money invested
ROCE
0.8%
Weak — 0.8% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+14.1%
Fast-growing sales (+14.1% YoY)
Profit growth
EPS YoY
-7.0%
Earnings shrinking (-7.0% YoY)

Slight earnings drop. Typical near a cyclical low.

How steady the profit is
EPS Consistency
7/8 quarters
Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
957%
Turns 957% of profit into real cash
Spare cash per sale
FCF Margin
14.7%
Converts sales into free cash efficiently (14.7%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.25
Conservative — low debt load (0.25)
Covers its interest
Interest Cover
0.39x
Dangerous — barely covers interest (0.4x)

Interest coverage below 1. Their profits don't cover the interest bill.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
79.6x
Expensive — P/E 79.6

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year
P/E vs Forward
+63.7
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (79.6 → 15.9)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial